Stay updated on Psilocybin in Anorexia Nervosa Clinical Trial
Sign up to get notified when there's something new on the Psilocybin in Anorexia Nervosa Clinical Trial page.

Latest updates to the Psilocybin in Anorexia Nervosa Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record describes a Phase 2 study evaluating the safety and potential effects of a single psilocybin dose with psychotherapy for adults with anorexia nervosa. It includes eligibility and study-plan details, outcome measures, collaborators, and related publications.SummaryDifference55%

- Check20 days agoChange DetectedThe ClinicalTrials.gov page’s footer revision label changed from v3.7.2 to v3.8.0. The page still displays a 403 error rather than the study record.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner appears with a link to NIH transition updates and a notice that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access is blocked. The site header and footer remain visible, but the main study content is inaccessible.SummaryDifference0.5%

Stay in the know with updates to Psilocybin in Anorexia Nervosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin in Anorexia Nervosa Clinical Trial page.